Skip to main content

Mouse Polyclonal ATP6V0D2 antibody. Suitable for WB and reacts with Recombinant fragment - Human, Human samples. Cited in 2 publications. Immunogen corresponding to Recombinant Fragment Protein within Human ATP6V0D2 aa 200 to C-terminus.


Images

Western blot - Anti-ATP6V0D2 antibody (AB194557), expandable thumbnail
  • Western blot - Anti-ATP6V0D2 antibody (AB194557), expandable thumbnail

Publications

Key facts

Isotype
IgG
Host species
Mouse
Storage buffer

Constituents: 50% Glycerol (glycerin, glycerine)

Form
Liquid
Clonality
Polyclonal

Immunogen

  • Recombinant Fragment Protein within Human ATP6V0D2 aa 200 to C-terminus. The exact immunogen used to generate this antibody is proprietary information. Database link Q8N8Y2

Reactivity data

Select an application
Product promiseTestedExpectedPredictedNot recommended
WB
Human
Tested
Mouse
Predicted
Rat
Predicted
Recombinant fragment - Human
Tested

Tested
Tested

Species
Recombinant fragment - Human
Dilution info
1/500 - 1/2500
Notes

-

Species
Human
Dilution info
1/500 - 1/2500
Notes

-

Predicted
Predicted

Species
Mouse, Rat
Dilution info
-
Notes

-

Associated Products

Select an associated product type

1 product for Alternative Product

Target data

Function

Subunit of the V0 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons. V-ATPase is responsible for acidifying and maintaining the pH of intracellular compartments and in some cell types, is targeted to the plasma membrane, where it is responsible for acidifying the extracellular environment (By similarity). May play a role in coupling of proton transport and ATP hydrolysis (By similarity). Regulator of osteoclast fusion and bone formation (By similarity).

Alternative names

Recommended products

Mouse Polyclonal ATP6V0D2 antibody. Suitable for WB and reacts with Recombinant fragment - Human, Human samples. Cited in 2 publications. Immunogen corresponding to Recombinant Fragment Protein within Human ATP6V0D2 aa 200 to C-terminus.

Key facts

Isotype
IgG
Form
Liquid
Clonality
Polyclonal
Immunogen
  • Recombinant Fragment Protein within Human ATP6V0D2 aa 200 to C-terminus. The exact immunogen used to generate this antibody is proprietary information. Database link Q8N8Y2
Purity
Whole antiserum
Concentration
Loading...

Storage

Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

ATP6V0D2 also known as V-type proton ATPase subunit d 2 is a subunit of the V-ATPase complex. It has a mass of approximately 38 kDa. This protein is expressed in various tissues with significant expression noted in bone and white adipose tissue. Mechanically ATP6V0D2 contributes to the acidification of intracellular compartments. It functions as part of the proton pump machinery facilitating the transfer of protons across membranes which is essential for processes like endocytosis and intracellular trafficking.

Biological function summary

ATP6V0D2 plays a significant role in bone resorption and adipogenesis. It is a component of the larger V-ATPase complex important for creating acidic environments required for enzyme activity particularly in osteoclasts. This acidity enables the breakdown of bone matrix which is a fundamental part of bone remodeling. Additionally ATP6V0D2 influences fat cell differentiation by modulating the function of cytosolic components within the complex.

Pathways

ATP6V0D2 functions as an integral part of the bone remodeling and lysosomal degradation pathways. In the bone remodeling pathway the protein works closely with other proton pump components like ATP6V0A3 to regulate osteoclast activity. In lysosomal degradation it aids in maintaining the acidity essential for lysosomal enzyme activity. Both pathways are connected through ATP6V0D2's regulation of intracellular pH and ion homeostasis.

Associated diseases and disorders

ATP6V0D2 has associations with osteoporosis and obesity. In osteoporosis deficient or dysfunctional ATP6V0D2 activity can impair osteoclast function leading to altered bone resorption and skeletal fragility. In the context of obesity this protein influences adipocyte differentiation and function. ATP6V0D2's role in these disorders connects it to other proteins like RANKL in bone metabolism and PPARγ in adipogenesis linking it beyond just its structural function within proton pumps.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Western blot - Anti-ATP6V0D2 antibody (ab194557), expandable thumbnail

    Western blot - Anti-ATP6V0D2 antibody (ab194557)

    All lanes: Western blot - Anti-ATP6V0D2 antibody (ab194557) at 1/500 dilution

    All lanes: Y79 cell lysate at 50 µg

    Predicted band size: 40 kDa

  • Western blot - Anti-ATP6V0D2 antibody (ab194557), expandable thumbnail

    Western blot - Anti-ATP6V0D2 antibody (ab194557)

    Expected MW of immunogen is 33.7 kDa.

    All lanes: Western blot - Anti-ATP6V0D2 antibody (ab194557) at 1/1000 dilution

    All lanes: recombinant immunogen at 0.2 µg

    Predicted band size: 40 kDa, 81 kDa

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com